What Researchers Did
Researchers conducted a review to summarize the therapeutic effects and underlying mechanisms of hyperbaric oxygen (HBO2) therapy for neuropathic pain (NPP).
What They Found
The review identified increasing numbers of basic and clinical studies investigating the efficacy and mechanisms of hyperbaric oxygen (HBO2) therapy for neuropathic pain (NPP). HBO2 therapy was noted for its advantages, including safety, few side effects, no resistance, and non-invasiveness, suggesting its potential as a treatment option.
What This Means for Canadian Patients
Canadian patients suffering from neuropathic pain, especially those for whom current treatments are insufficient or cause severe side effects, might benefit from hyperbaric oxygen therapy. This therapy could offer a non-invasive alternative with a favorable safety profile, potentially improving pain management and quality of life.
Canadian Relevance
This review does not have a direct Canadian connection as it was not conducted by Canadian researchers nor focused on Canadian populations.
Study Limitations
As a review, this paper synthesizes existing literature but does not present new primary data or address potential biases in the included studies.